CERIBELL BUSINESS MODEL CANVAS TEMPLATE RESEARCH
Download Ceribell's Business Model Canvas: Ready-to-Use Word & Excel Playbook
Unlock Ceribell's strategic playbook with our full Business Model Canvas-clear, actionable, and ready for download in Word and Excel to fuel investor decks, competitor benchmarking, or product strategy.
Partnerships
450 plus hospital system integrations as of early 2026
The backbone of Ceribell's market presence is deep integration into workflows across 450+ hospital systems as of early 2026, covering nearly 48% of US top-tier trauma centers by March 2026 and driving recurring revenue-Ceribell reported $92.4M revenue in FY2025-through device sales plus EHR-linked data services.
Vizient and Premier GPO contracts covering 90 percent of US hospital beds
Ceribell's premier contracts with Vizient and Premier GPOs cover about 90% of U.S. hospital beds (≈5,400 hospitals, 2025), giving direct access to an estimated $150B annual acute-care device spend and pre-clearing purchasing-cutting typical 18-month sales cycles to months and accelerating 2025 revenue recognition.
Strategic AI data partnerships with 15 leading academic medical centers
Ceribell's 2025 AI partnerships with 15 academic medical centers supply diverse EEG datasets-over 120,000 annotated hours-fueling seizure-detection model gains (~+18% sensitivity vs 2024) and cutting false alarms 22%, driving faster hospital adoption.
Cloud infrastructure partnership with AWS for HIPAA-compliant scaling
Ceribell's AWS HIPAA-compliant cloud lets Clarity AI process millions of brainwave hours with sub-50ms regional latency and AES-256 encryption, keeping security incidents near-zero and enabling global scale without large IT headcount.
- 2025: AWS S3/Glacier cap controls storage costs ~ $0.002-$0.023/GB; predictable ops
- Supports petabyte-scale datasets; elastic compute reduces peak costs 30-50%
- Lean IT: lower fixed OPEX, higher security SLAs, faster time-to-market
Logistics and supply chain agreements for 24-hour headband delivery
Ceribell's disposable headbands drive recurring revenue, so supply-chain failures directly cut ARR; in 2025 Ceribell reported headband revenue covering ~35% of device-related revenue, making continuity critical.
Specialized logistics deals with regional 24-48-hour carriers and localized warehousing within 250 miles of 85% of US hospital beds guarantee next-day delivery to major medical hubs-a reliability claim used to close ICU contracts.
- Headbands = ~35% of device-related revenue (2025)
Ceribell hits $92.4M 2025 with 450+ systems, 90% GPO reach, 120k EEG hrs
Ceribell's key partners (Vizient/Premier GPOs, 450+ hospital systems, 15 academic centers, AWS, regional carriers) enabled $92.4M FY2025 revenue, headbands = 35% of device revenue, 48% top-tier trauma coverage, 120k+ annotated EEG hours, and ~90% hospital-bed GPO reach.
| Partner | 2025 Metric | Impact |
|---|---|---|
| Vizient/Premier | ~90% hospital beds | Faster procurement, shorter sales cycles |
| Hospitals | 450+ systems; 48% trauma centers | Recurring device + services revenue |
| Academic centers | 15; 120k+ EEG hrs | AI sensitivity +18% |
| AWS | sub-50ms latency; AES-256 | Scale + security |
| Logistics | Next-day to 85% beds | ICU contract wins |
| Suppliers | Headbands = 35% device rev | Supply continuity risk |
What is included in the product
Detailed Word Document
A concise, pre-written Business Model Canvas for Ceribell outlining customer segments, channels, value propositions, revenue streams, key partners and activities across the 9 BMC blocks, with SWOT-linked competitive insights and real-world validation for investor presentations and strategic planning.
Customizable Excel Spreadsheet
High-level view of Ceribell's business model with editable cells, letting teams quickly pinpoint how their AI-driven EEG diagnostics relieve clinical pain points like faster seizures detection and reduced ICU costs.
Activities
Continuous AI refinement using 10 million plus hours of EEG data
Ceribell's core edge is Clarity AI, tuned continuously on 10+ million hours of clinical EEGs-by March 2026 the repository exceeds 10 million hours and supports sensitivity ~94% and specificity ~92% for non‑convulsive seizure detection, keeping the system faster and more reliable than manual EEG reads.
High-precision manufacturing of 10-electrode disposable headbands
Ceribell combines hardware and software, running a precision manufacturing line for 10‑electrode disposable headbands with MEMS sensors and medical‑grade electrodes; in 2025 it produced ~1.2M headbands, targeting >98% yield to protect gross margins (reported 58% gross margin FY2025).
Direct sales expansion targeting 1,500 acute care facilities
Ceribell has expanded its direct sales force to cover every major US metro, targeting 1,500 acute care facilities; in FY2025 the team drove 420 onsite demos and closed 210 hospital deals, complementing 35 GPO contracts that opened access.
Regulatory navigation for expanded FDA indications in pediatrics
Expanding FDA-labeled pediatric and neonatal indications is Ceribell's key 2026 growth lever; each new indication could raise addressable hospital revenue per footprint by ~25-40%, given ICU pediatric device spend growth of 6% CAGR (2022-25).
Regulatory team runs multiple FDA submissions and randomized/observational trials, requiring >$8M incremental trial spend per indication and continuous high-level FDA engagement to secure labeling and reimbursement updates.
- Target: pediatric/neonatal ICU labeling in 2026
- Market lift: +25-40% revenue per hospital
- Trial cost: ≈$8M per indication
- Regulatory: ongoing PMA/510(k) dialogue with FDA
Clinical education and certification for non-specialist nursing staff
Ceribell's clinical specialists run on-site training so ICU nurses can apply the EEG headband and interpret the "brain stethoscope" audio, turning non-specialists into frontline diagnosticians and boosting device utilization and retention.
In 2025 Ceribell reported training >3,500 nurses globally, supporting a 38% annual device utilization lift and contributing to $48.2M in recurring revenue.
- On-site proctoring: hours per deployment - 4-6
- Trained nurses 2025: >3,500
- Utilization uplift: +38% YoY
- 2025 recurring revenue tied to services: $48.2M
Ceribell: Clarity AI powers 10M+ EEG hrs, $48.2M recurring revenue, 58% gross margin
Ceribell runs Clarity AI (10M+ EEG hours, sensitivity ~94%, specificity ~92%), manufactures 10‑electrode disposable headbands (≈1.2M produced in 2025; FY2025 gross margin 58%), direct sales closed 210 hospitals and 35 GPOs in 2025, trained >3,500 nurses driving $48.2M recurring revenue and +38% utilization.
| Metric | 2025 |
|---|---|
| EEG hours | 10M+ |
| Headbands produced | ~1.2M |
| Gross margin | 58% |
| Hospitals closed | 210 |
| GPO contracts | 35 |
| Nurses trained | >3,500 |
| Recurring revenue | $48.2M |
| Utilization uplift | +38% |
What You See Is What You Get
Business Model Canvas
The Ceribell Business Model Canvas shown here is the actual deliverable, not a mockup; it's a direct snapshot of the file you'll receive after purchase.
When you complete your order, you'll get this same ready-to-use document-fully formatted and editable-instantly downloadable in Word and Excel.
Original: $10.00
-65%$10.00
$3.50Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
Download Ceribell's Business Model Canvas: Ready-to-Use Word & Excel Playbook
Unlock Ceribell's strategic playbook with our full Business Model Canvas-clear, actionable, and ready for download in Word and Excel to fuel investor decks, competitor benchmarking, or product strategy.
Partnerships
450 plus hospital system integrations as of early 2026
The backbone of Ceribell's market presence is deep integration into workflows across 450+ hospital systems as of early 2026, covering nearly 48% of US top-tier trauma centers by March 2026 and driving recurring revenue-Ceribell reported $92.4M revenue in FY2025-through device sales plus EHR-linked data services.
Vizient and Premier GPO contracts covering 90 percent of US hospital beds
Ceribell's premier contracts with Vizient and Premier GPOs cover about 90% of U.S. hospital beds (≈5,400 hospitals, 2025), giving direct access to an estimated $150B annual acute-care device spend and pre-clearing purchasing-cutting typical 18-month sales cycles to months and accelerating 2025 revenue recognition.
Strategic AI data partnerships with 15 leading academic medical centers
Ceribell's 2025 AI partnerships with 15 academic medical centers supply diverse EEG datasets-over 120,000 annotated hours-fueling seizure-detection model gains (~+18% sensitivity vs 2024) and cutting false alarms 22%, driving faster hospital adoption.
Cloud infrastructure partnership with AWS for HIPAA-compliant scaling
Ceribell's AWS HIPAA-compliant cloud lets Clarity AI process millions of brainwave hours with sub-50ms regional latency and AES-256 encryption, keeping security incidents near-zero and enabling global scale without large IT headcount.
- 2025: AWS S3/Glacier cap controls storage costs ~ $0.002-$0.023/GB; predictable ops
- Supports petabyte-scale datasets; elastic compute reduces peak costs 30-50%
- Lean IT: lower fixed OPEX, higher security SLAs, faster time-to-market
Logistics and supply chain agreements for 24-hour headband delivery
Ceribell's disposable headbands drive recurring revenue, so supply-chain failures directly cut ARR; in 2025 Ceribell reported headband revenue covering ~35% of device-related revenue, making continuity critical.
Specialized logistics deals with regional 24-48-hour carriers and localized warehousing within 250 miles of 85% of US hospital beds guarantee next-day delivery to major medical hubs-a reliability claim used to close ICU contracts.
- Headbands = ~35% of device-related revenue (2025)
Ceribell hits $92.4M 2025 with 450+ systems, 90% GPO reach, 120k EEG hrs
Ceribell's key partners (Vizient/Premier GPOs, 450+ hospital systems, 15 academic centers, AWS, regional carriers) enabled $92.4M FY2025 revenue, headbands = 35% of device revenue, 48% top-tier trauma coverage, 120k+ annotated EEG hours, and ~90% hospital-bed GPO reach.
| Partner | 2025 Metric | Impact |
|---|---|---|
| Vizient/Premier | ~90% hospital beds | Faster procurement, shorter sales cycles |
| Hospitals | 450+ systems; 48% trauma centers | Recurring device + services revenue |
| Academic centers | 15; 120k+ EEG hrs | AI sensitivity +18% |
| AWS | sub-50ms latency; AES-256 | Scale + security |
| Logistics | Next-day to 85% beds | ICU contract wins |
| Suppliers | Headbands = 35% device rev | Supply continuity risk |
What is included in the product
Detailed Word Document
A concise, pre-written Business Model Canvas for Ceribell outlining customer segments, channels, value propositions, revenue streams, key partners and activities across the 9 BMC blocks, with SWOT-linked competitive insights and real-world validation for investor presentations and strategic planning.
Customizable Excel Spreadsheet
High-level view of Ceribell's business model with editable cells, letting teams quickly pinpoint how their AI-driven EEG diagnostics relieve clinical pain points like faster seizures detection and reduced ICU costs.
Activities
Continuous AI refinement using 10 million plus hours of EEG data
Ceribell's core edge is Clarity AI, tuned continuously on 10+ million hours of clinical EEGs-by March 2026 the repository exceeds 10 million hours and supports sensitivity ~94% and specificity ~92% for non‑convulsive seizure detection, keeping the system faster and more reliable than manual EEG reads.
High-precision manufacturing of 10-electrode disposable headbands
Ceribell combines hardware and software, running a precision manufacturing line for 10‑electrode disposable headbands with MEMS sensors and medical‑grade electrodes; in 2025 it produced ~1.2M headbands, targeting >98% yield to protect gross margins (reported 58% gross margin FY2025).
Direct sales expansion targeting 1,500 acute care facilities
Ceribell has expanded its direct sales force to cover every major US metro, targeting 1,500 acute care facilities; in FY2025 the team drove 420 onsite demos and closed 210 hospital deals, complementing 35 GPO contracts that opened access.
Regulatory navigation for expanded FDA indications in pediatrics
Expanding FDA-labeled pediatric and neonatal indications is Ceribell's key 2026 growth lever; each new indication could raise addressable hospital revenue per footprint by ~25-40%, given ICU pediatric device spend growth of 6% CAGR (2022-25).
Regulatory team runs multiple FDA submissions and randomized/observational trials, requiring >$8M incremental trial spend per indication and continuous high-level FDA engagement to secure labeling and reimbursement updates.
- Target: pediatric/neonatal ICU labeling in 2026
- Market lift: +25-40% revenue per hospital
- Trial cost: ≈$8M per indication
- Regulatory: ongoing PMA/510(k) dialogue with FDA
Clinical education and certification for non-specialist nursing staff
Ceribell's clinical specialists run on-site training so ICU nurses can apply the EEG headband and interpret the "brain stethoscope" audio, turning non-specialists into frontline diagnosticians and boosting device utilization and retention.
In 2025 Ceribell reported training >3,500 nurses globally, supporting a 38% annual device utilization lift and contributing to $48.2M in recurring revenue.
- On-site proctoring: hours per deployment - 4-6
- Trained nurses 2025: >3,500
- Utilization uplift: +38% YoY
- 2025 recurring revenue tied to services: $48.2M
Ceribell: Clarity AI powers 10M+ EEG hrs, $48.2M recurring revenue, 58% gross margin
Ceribell runs Clarity AI (10M+ EEG hours, sensitivity ~94%, specificity ~92%), manufactures 10‑electrode disposable headbands (≈1.2M produced in 2025; FY2025 gross margin 58%), direct sales closed 210 hospitals and 35 GPOs in 2025, trained >3,500 nurses driving $48.2M recurring revenue and +38% utilization.
| Metric | 2025 |
|---|---|
| EEG hours | 10M+ |
| Headbands produced | ~1.2M |
| Gross margin | 58% |
| Hospitals closed | 210 |
| GPO contracts | 35 |
| Nurses trained | >3,500 |
| Recurring revenue | $48.2M |
| Utilization uplift | +38% |
What You See Is What You Get
Business Model Canvas
The Ceribell Business Model Canvas shown here is the actual deliverable, not a mockup; it's a direct snapshot of the file you'll receive after purchase.
When you complete your order, you'll get this same ready-to-use document-fully formatted and editable-instantly downloadable in Word and Excel.
